Status:
COMPLETED
Rapid Eye Movement Related OSA in Diabetic Versus Non-Diabetic Patients Treated With PCI
Lead Sponsor:
National University of Singapore
Collaborating Sponsors:
National Heart Centre Singapore
Conditions:
Obstructive Sleep Apnea
Diabetes Mellitus
Eligibility:
All Genders
22-99 years
Brief Summary
The primary objective of the Sleep and Stent II is to determine the prevalence of REM-OSA in DM versus non-DM patients undergoing clinically indicated PCI. The secondary objectives are to investigate...
Detailed Description
The Sleep and Stent II is a cross-sectional study of patients who have undergone PCI for coronary artery disease. A total of 200 adult patients who have undergone clinically indicated PCI between 6 an...
Eligibility Criteria
Inclusion
- Age \>21 years old Have undergone clinically indicated PCI between 6 and 36 months ago
Exclusion
- Known OSA on treatment Clinical instability with admission for acute coronary syndrome, heart failure or stroke in the past 30 days Inability to give informed consent
Key Trial Info
Start Date :
June 4 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT03479788
Start Date
June 4 2018
End Date
September 30 2019
Last Update
March 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lee Chi-Hang Ronald
Singapore, Singapore, 119228